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Background: Wedelia chinensis is traditionally used as a hepatoprotective herb in Taiwan. The aim of this study was
to evaluate the neuroprotective potential of W. chinensis.
Methods: An ethyl acetate extract of W. chinensis (EAW) was prepared and analyzed by HPLC. The neuroprotective
potential of EAW was assessed by tert-butylhydroperoxide (t-BHP)-induced damage in PC12 cells and D-galactose-
induced damage in mouse cortex.
Results: EAW exhibited potent radical scavenging property and highly contained luteolin and wedelolactone.
EAW decreased t-BHP-induced reactive oxygen species (ROS) accumulation, cytotoxicity and apoptosis in PC12
cells. EAW and its major constituents blocked t-BHP-induced cytochrome C release and Bcl-2 family protein ratio
change. EAW and its major constituents increased the endogenous antioxidant capacity evaluated by the binding
activity assay of nuclear factor E2-related factor 2 (Nrf2) to antioxidant response element (ARE) and nuclear
translocation of Nrf2 respectively in PC12 cells. Finally, EAW inhibited D-galactose-induced lipid peroxidation, apoptosis
and neuron loss in the cerebral cortex of mice.
Conclusion: These results demonstrate that W. chinensis has neuroprotective potential through blocking oxidative
stress-induced damage and that luteolin and wedelolactone contribute to the protective action.
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Oxidative tress occurs when the production of reactive
oxygen species (ROS) or their products are in excess of
antioxidant defense mechanism. The brain is especially
vulnerable to oxidative stress compared to other organs
because it exhibits lower antioxidant enzyme activity and
contains an abundance of unsaturated fatty acids, which are
the targets of lipid peroxidation. Thereafter oxidative stress
contributes to the neurodegenerative disorders, and is one
of the earliest pathological changes in Alzheimer’s disease
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unless otherwise stated.combat the ROS generation and block ROS-mediated
deleterious effects by gene regulation. Supplementa-
tions with exogenous antioxidants from diets as well as
medicinal herbs catch attention on avoid unwanted
neuropathophysiology.
Tertiary butyl hydroperoxide (t-BHP), a simple lipophilic
alkyl hydroperoxide, has been reported to induce dose-
dependent oxidative stress and damage in brain cells [2].
The alkoxyl and alkyl radicals derived from t-BHP are
a species that produce cell damage [3,4]. Furthermore,
t-BHP-induces a cellular redox imbalance may induce
cell apoptosis [5]. Therefore, t-BHP is a useful inducer
for investigating the effectiveness of various neuropro-
tection products against oxidative stress. In addition,
D-galactose at normal concentrations can be metabo-
lized by D-galactokinase and galactose-1-phosphates is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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converted into aldose and hydroperoxide by galactose
oxidase, resulting in the generation of ROS in the
brain [6,7], which can affect bimolecules including
protein, DNA and lipids and which may lead to con-
secutive functional disturbance and cell death. Thus,
treatment of animals with D-galactose may serve as a
useful model for studying the effect of neuroprotective
agents.
Wedelia chinensis, a Wedelia genus plant belonging to
the Compositae, has been traditionally used as a hepa-
toprotective tea material in Taiwan [8]. W. chinensis
possesses multiple activities such as anti-microbial, anti-
inflammatory, anti-cancer, and CNS-depressant activity
[9-11]. Previously, Lin reported that W. chinensis con-
tained four compounds capable of suppressing androgen
activity: luteolin, apigenin, indole-3-carboxyaldehyde and
wedelolactone [12]. Luteolin and apigenin, belonging to
flavonoid structure, have been reported to reveal anti-
oxidant, anti-inflammatory, and anti-cancer effects [13-15].
Wedelolactone, belonging to coumarin structure, has been
demonstrated to exhibit a wide range of biological effects
including anti-inflammation, immunomodulatory, anti-
myotoxic, anti-oxidant, anti-phlogistic, anti-haemorrhagic,
anti-hepatotoxic and anti-cancer activity [16-20]. Since the
neuroprotection potential of W. chinensis is not well under-
stood, in the present study we used two models, in vitro
and in vivo, to evaluate its neuroprotective potential.
Methods
Reagents and materials
Dulbecco’s modified Eagle’s medium (DMEM), fetal bo-
vine serum, and penicillin/streptomycin were purchased
from GIBCO Ltd. (Grand Island, NY, USA). Antibodies,
such as anti-Bcl-2, −Bcl-XL, -Bax, −Nrf2 and -β-actin
antibodies were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA). The herb, W. chinensis, was purchased
from a reputable folk medicine store in Taiwan and identi-
fied by associate professor Ko-Kaung Liao, who majors in
Biology and is familiar with medicinal plants. Wedelolac-
tone, 7-methoxy-5, 11, 12-trihydroxy-coumestan, was syn-
thesized from commercially available phloroglucinol [21].
All chemicals were analytical grade purchased from
Sigma-Aldrich (USA) and Merck (Germany).
Preparation of the crude extract
The air-dried whole plant of W. chinensis was shredded
in a blender and extracted with 5 volumes of 95% etha-
nol at room temperature for 2 days. The mixture was fil-
tered through filter paper (5 μm pore size), and the
filtrate was dried using rotary evaporation under vacuum
at 40°C. The percentage yield was 9.3% (w/w). The crude
ethanolic extract was suspended in distilled water and
partitioned successively with n-hexane and ethyl acetate,respectively to obtained semi-crudes. All dried extracts,
including ethanol extract, n-hexane extract (HEW), and
ethyl acetate extract (EAW) were stored at −20°C prior
to use in the following studies.
DPPH radical scavenging assay
The 2,2-diphenyl-1-picrylhydrazyl (DPPH) method mea-
sures the reaction of the antioxidants with the stable
DPPH radical in a methanol solution. Briefly, a 60 μM
DPPH radical solution was freshly made in methanol.
Various concentrations of the sample extracts were
reacted with the DPPH radical solution (3 mL) for
45 min at room temperature, and the absorbance was
measured at 517 nm. The affinity of the test material to
quench the DPPH free radical was evaluated according
to the equation scavenging % = (absorbance of control
group–absorbance of the extract added group)/absorb-
ance of control group × 100%.
HPLC analysis
EAW was analyzed using a Hitachi L7100 HPLC system
with a 5-μm ODS-Hypersil column (250 × 4.6 mm). The
mobile phase was generated from solvent A [acetonitrile:
H2O: acetic acid (90:10:3)] and solvent B [acetonitrile:
H2O: acetic acid (10:90:3)] using the following gradient
program: 0–3 min 100% solvent B, 3–8 min 85% solvent
B, 8–15 min 80% solvent B, 15–40 min 60% solvent B.
The detection wavelength was 360 nm, and the flow rate
0.8 mL/min. Quantization was carried out by the exter-
nal standard method on the basis of the area at 360 nm
using calibration curve of wedelolactone and luteolin.
Cell culture
Adrenal pheochromocytoma (PC12) cells were main-
tained in DMEM medium containing 5% fetal bovine
serum, 10% horse serum, and 100 U/mL penicillin and
streptomycin in a 5% CO2 incubator at 37°C.
Preparation of nuclear protein and analysis of
antioxidant-response element (ARE) binding activity of
nuclear factor E2-related factor 2(Nrf2)
PC12 cells (1 × 106 cells/ml) were exposed to the indi-
cated reagent or vehicle (0.1% DMSO) for 6 h. Nuclear
extracts were harvested using NE-PER nuclear extrac-
tion reagent (Thermo Fisher Scientific, Rockford, IL,
USA) according to the manufacture’s instructions. Nu-
clear protein concentrations were determined using the
Bio-Rad protein assay reagent. The amount of Nrf2
available in the nucleus to bind AREs was determined
using a TransAM Nrf2 Transcription Factor ELISA Kit
(Active Motif Inc., Carlsbad, CA, USA) according to the
manufacturer’s instructions. Briefly, nuclear extracts
(2.5 μg) were added to wells that contained the immobi-
lized consensus ARE oligonucleotide. A primary anti-Nrf2
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peroxidase-conjugated secondary antibody. The signal was
detected at 450 nm, and Nrf/ARE binding activity is
reported as A450.
Intracellular ROS analysis
PC12 cells were pretreated with EAW for 24 h and then
treated with or without 100 μM of t-BHP for 3 h. After
the indicated treatments, PC12 cells were incubated with
the fluorescent probe 2′,7′-dichlorofouorescein diacetate
(DCFH-DA; 10 μM) for 30 min. DCFH-DA becomes
highly fluorescent 2′,7′-dichlorofouorescein (DCF) upon
oxidation by ROS, and then washed twice with PBS.
Finally the fluorescence intensity of DCF was measured
in a microplate reader with an excitation wavelength
485 nm and an emission wavelength of 535 nm.
Determination of cytotoxicity by LDH release assays
Cells were seeded in 24-well plates at a density of 2 × 105
cells/ml. PC12 cells were pretreated with EAW (0, 10, 25
and 50 μg/mL) for 24 h and then treated with or without
100 μM of t-BHP for 3 h. The cytotoxicity was quantita-
tively assessed by measuring the activity of the lactate de-
hydrogenase (LDH) released from the damaged cells into
the culture medium. At the end of the treatment, the
media was used for the LDH activity assay. The enzyme
was determined by using an assay kit according to the
manufacturer’s protocol. The absorbance of the samples
was read at 490 nm using a microplate reader. The LDH
release was proportional to the number of damaged PC12
cells.
Sub-G0/G1 hypodiploid FACS analysis
After treatment, the cells were fixed with ice-cold 70%
ethanol overnight. The cells were then centrifuged at
1500 g for 10 min and resuspended in PBS containing
0.5% Triton X-100, 0.1 mg/mL RNase, and 40 μg/mL
propidium iodide (PI) at room temperature for 30 min.
Cellular DNA content (10,000 cells per analysis) was de-
termined by flow cytometric analysis of PI-labeled cells
using a FACSCalibur flow cytometer (Becton Dickinson,
San Jose, CA) equipped with a single argon-ion laser
(488 nm). Cell cycle was analyzed using Modfit software
(Verity Software House, Topsham, ME) and those cells
in apoptosis were indicated by the substantially lower
DNA content compared to the G0/G1 peak in the DNA
histogram.
Western blotting analysis
The cells were washed in PBS with 1 mM zinc ion and
lysed in radioimmunoprecipitation assay (RIPA) buffer
(50 mM Tris-buffer, 5 mM EDTA, 150 mM NaCl, 1%
NP 40, 0.5% deoxycholic acid, 1 mM sodium orthovana-
date, 81 μg/mL aprotinin, 170 μg/mL leupeptin, and100 μg/mL PMSF; pH 7.5). The mixtures were mixed for
30 min at 4°C and centrifuged (10,000 g) for 10 min.
The supernatants were collected as whole-cell extracts.
The protein content was determined with the Bio-Rad
protein assay reagent using bovine serum albumin as a
standard. Protein samples (50 to 100 μg protein) were
boiled, separated on an SDS polyacrylamide gel, electro-
phoretically transferred to nitrocellulose membranes
(Amersham, Arlington Heights, IL) and blotted with the
indicated primary antibodies. The proteins were visualized
with horseradish peroxidase (HRP)-conjugated secondary
antibodies (Zymed Laboratory, Inc., San Francisco, CA)
followed by chemiluminescence (ECL-Plus; Santa Cruz
Biotechnology). The relative photographic density was
quantified using densitometry.
Assessment of cytochrome C release
Cells were harvested and washed with ice-cold PBS at the
end of treatment to prepare the cytosolic fraction. The cell
pellet was resuspended in 500 μL buffer A (20 mM
HEPES-KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM
sodium EDTA, 1 mM leupeptin and 1 μg/mL chymostatin)
and homogenized using a Pyrex glass homogenizer and a
type B pestle (40 strokes). The homogenate was centrifuged
at 100,000 g (4°C for 1 h) to generate the cytosolic fraction.
A Bio-Rad protein assay kit determined protein concentra-
tions, and 25 μg of each fraction was separated using 15%
SDS-PAGE. The proteins were transferred to an NC mem-
brane, and then reacted sequentially with a primary antibody
(anti-cytochrome C and anti-β-actin as internal controls)
and a secondary peroxidase-conjugated antibody. Protein
bands were revealed using enhanced chemiluminescence
(ECL commercial kit).
Animals and treatments
Five-week-old male ICR mice were purchased from Gly-
coNex Inc. (Taiwan) and kept in groups of three to four
per cage in an animal room at a temperature of 22 ± 2°C,
12 h light–dark cycle, and relative humidity 50-70%. The
mice were provided with rodent chow and water ad libi-
tum. All experiments were approved by the Animal Care
Committee of Chung Shan Medical University (IACUC
approval No. 896). After adaptation for a week, the mice
were randomly divided into 4 groups (n = 6). Group 1
served as the vehicle control and received daily subcuta-
neous (s.c.) injections of 0.1 mL of distilled water and
three intraperitoneal (i.p.) injections/week of 1% DMSO
in distilled water for 9 weeks. Group 2 received daily s.c.
injections of 50 mg/kg of D-galactose in distilled water
and three i.p. injections/week of 0.1 mL of 1% DMSO in
distilled water for 9 weeks. Groups 3 and group 4 re-
ceived the same s.c. injections of D-galactose plus three
i.p. injections/week of 0.1 mL of 1% DMSO containing,
respectively, 10 mg/kg or 25 mg/kg of EAW.
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peroxidation
Mice were euthanized and the brain removed and dis-
sected on an ice-bath plate. The right cerebral cortex was
fixed in 10% paraformaldehyde for histological studies and
the left cerebral cortex was homogenized in 10 volumes
(v/w) of ice-cold saline containing a protease inhibitor
cocktail (Sigma-Aldrich, MO, USA). The resultant hom-
ogenate was centrifuged and the supernatant was removed
for lipid peroxidation determination. The amount of mal-
ondialdehyde (MDA) was measured by reaction with thio-
barbituric acid and the absorbance read at 532 nm on a
spectrophotometer.
TUNEL staining and histopathological examination
The cerebral cortex samples were dehydrated, embedded in
paraffin blocks after post-fixation, then sliced and the sec-
tions stained with terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL). The TUNEL positive
cells were visualized using the peroxidase-DAB reaction
and counterstained with hematoxylin. Detailed procedures
followed the manufacturer’s protocol for the in situ Apop-
tosis Detection Kit (In Situ Cell Death Detection Kit; Roche
Diagnostics, Mannheim, Germany) according to the manu-
facturer’s instructions. The digital images were captured
using a digital camera (Canon A640, Tokyo, Japan). Quanti-
fication of apoptotic cells was by measuring three randomly
selected microscopic fields (100× magnification) for each
slide. The percentage of TUNEL-positive cell (%) = 100 ×
(TUNEL-positive cells/total cells). In addition, the sections
were stained with hematoxylin-eosin for light microscopic
analysis. Large nuclei and dark staining neurons in the
cerebral cortex were counted in five random fields per slide
at 400× magnification and the density of neurons expressed
as no./mm2.
Statistical analysis
Statistical significance was determined using one-way
analysis of variance (ANOVA) followed by Dunnett’s or
Tukey’s post hoc test. P values less than 0.05 were con-
sidered statistically significant.
Results and discussion
Free radical scavenging activity and main constituent of
EAW
Bleaching of DPPH was performed to determine the free
radical scavenging capacity of the crude extracts. In our
preliminary study, ethanol extract of W. chinensis exhib-
ited free radical scavenging activity, and after solvent
partition, it showed EAW increased the potency of free
radical scavenging activity, with 10 μg/mL of EAW quench-
ing ~50% of free radicals (Figure 1A). Then HPLC analysis
examined the composition of EAW as compared with the
authentic samples. This demonstrated that wedelolactoneand luteolin were the main constituents (retention time
19.02 min and 28.15 min) (Figure 1B). The content of
wedelolatone in EAW was 12.8% and luteolin was 11.4%
respectively.
EAW activates nuclear Nrf2-ARE binding activity
Figure 1 shows that EAW exhibited radical scavenging ac-
tivity. In addition to direct scavenging radicals, whether
noncytotoxic concentration of EAW has antioxidant en-
zyme induction activity in PC12 cells was investigated.
The antioxidant response element (ARE) is a cis-acting
enhancer sequence found in the promoter region of many
genes encoding antioxidant enzymes/proteins. Nrf2 is a
major ARE-binding transcription factor and induces the
expression of antioxidant enzymes. Thereafter, whether
EAW can enhance binding activity of nuclear Nrf2 to the
ARE was evaluated. It was found that treatment with non-
cytotoxic concentration of EAW (25 and 50 μg/mL)
significantly activated Nrf2–binding activity (Figure 2).
Effects of EAW on t-BHP-induced intracellular ROS,
cytotoxicity and apoptosis
The intracellular level of ROS with or without EAW treat-
ment prior to t-BHP exposure was evaluated. The treat-
ment of PC12 cells with 100 μM t-BHP for 3 h increased
DCF fluorescence. It implicated t-BHP induced intracellu-
lar ROS. In our preliminary study, pretreatment of EAW
for 6 h didn’t exhibited apparent reduction effect on
t-BHP-induced intracellular ROS (data not shown). How-
ever, pretreatment of EAW for 24 h showed reducing ef-
fect significantly (Figure 3). Thereafter, pretreatment of
EAW for 24 h was used in the following cell culture study.
LDH is a stable cytoplasmic enzyme that is present in all
cells, including neurons. LDH is rapidly released into the
cell culture medium when the cell plasma membrane is
damaged. Therefore, LDH is a reliable biochemical index
for neuronal cytotoxicity. Treatment with t-BHP for 3 h in-
creased LDH release into the medium to 123.0 ± 3.3% of
control (Figure 4A). Pretreatment with different EAW con-
centrations prior to t-BHP exposure significantly inhibited
LDH leakage in the PC12 cell system compared to t-BHP
treated alone group (Figure 4A). The flow cytometry ana-
lysis was used to evaluate the t-BHP-induced apoptosis of
PC12 cells (Figure 4B). It showed t-BHP-induced 23.21%
sub-G0/G1 phase, which indicated DNA degradation and
the cells undergoing apoptosis. With the pretreatment of
25 and 50 μg/mL EAW significantly declined to 16.83%
and 11.30% respectively compared to t-BHP treated alone
group (Figure 4B).
Effects of EAW and its major constituents on t-BHP-
induced changes in cytochrome C and the Bcl-2 family
Oxidative stress initiates mitochondrial apoptotic signals
[22,23]. The loss of mitochondrial cytochrome C and its
AB
Figure 1 DPPH quenching effect and HPLC analysis of Wedelia chinesis extract. (A) The indicated concentrations of the ethanol extract,
hexane extract (HEW), and ethyl acetate extract (EAW) of Wedelia chinensis were evaluated for DPPH quenching capacity as described in the text.
% of DPPH scavengering activity = (absorbance of control group – absorbance of the extract added group)/absorbance of control group × 100%.
Means ± SD (n = 3). (B) HPLC analysis of EAW. For the conditions, see the Materials and Methods. Peak 1 is wedelolactone, and peak 2 is luteolin.
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tiation of mitochondrial caspase signaling. It was found
that t-BHP treatment increased cytosolic cytochrome C,
which was decreased by pretreatment with EAW or
luteolin or wedelolactone (Figure 5A). The Bcl-2 family
members have been found to play important roles in
regulating mitochondrial-mediated apoptosis. High ratio
of Bcl-2/Bax and Bcl-XL/Bax were observed to promote
cell survival by preserving the integrity of the external
mitochondrial membrane, which prevents the releasedof cytochrome C from the mitochondria, inducing cell
death. It has been reported that overexpression of Bcl-2
in neurons was found to protect from neuronal loss in
mouse model of cerebral ischemia [24]. In addition, Bax
inhibition prevented neuronal death in a mouse model
of Parkinson’s disease [25]. The ratio of Bcl-2/Bax and
Bcl-XL/Bax are important in determining sensitivity to
apoptotic stimuli. Therefore, we determined the effect of
EAW, luteolin and wedelolactone on t-BHP–induced
changes in these proteins. The treatment of PC12 cells
Figure 2 Effects of EAW on Nrf2 activation. After pretreatment with EAW, PC12 cells were harvested and nuclear extracts were prepared and
analyzed using the TransAM Nrf2 kit, as described in the Materials and Methods. Data represent the means ± SD (n = 3). *P < 0.05, versus solvent
control (0.1% DMSO) treated alone.
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Bax and Bcl-XL/Bax significantly, which were reversed by
the pretreatment of EAW or luteolin or wedelolactone
(Figure 5B). However, PC12 cells cannot totally represent
the characters of primary cultured neurons, so, the further
work needs to focus directly on primary neurons.
Effects of luteolin and wedelolactone on nuclear
translocation of Nrf2 and γ-GCS expression
It has been demonstrated that some antioxidants are exert-
ing their antioxidative effect by activating Nrf2, which is aFigure 3 Effects of EAW on t-BHP-induced intracellular ROS level. Afte
DCFH-DA as described in the text. ## P < 0.01, compared to the solvent co
treatment alone.master regulator of the antioxidant response [26]. Activa-
tion of Nrf2 requires its translocation into the nucleus. It
showed luteolin and wedelolactone increased the nuclear
translocation of Nrf2, which implicated activation of Nrf2
(Figure 6). In addition, luteolin and wedelolactone in-
creased the protein expression of γ-glutamyl-cysteine syn-
thetase (γ-GCS), a product of Nrf2 target gene (Figure 6).
Luteolin and wedelolactone containing phenolic structure
have been reported to exhibit free radical quenching prop-
erties [27,28]. Therefore, luteolin as well as wedelolactone
contributed to the neuroprotective potential of EAW byr treatment, the intracellular ROS were determined using labeling with
ntrol (0.1% DMSO). *P < 0.05 and **P < 0.01, compared to t-BHP
AB
Figure 4 Effects of EAW on t-BHP-induced cytotoxicity and apoptosis in PC12 cells. PC12 cells were pretreated with EAW (0, 10, 25 and
50 μg/mL) for 24 h and then treated with or without 100 μM of t-BHP for 3 h. (A) The cytotoxicity was determined by the LDH assay kit. (B) The
DNA content was analyzed by the flow cytometry as described in the text (upper panel). The percentage of apoptotic cells (sub-G1 phase) is expressed
as mean ± SD (n = 3). ## P < 0.01, compared to the solvent control (0.1% DMSO). *P < 0.05 and **P < 0.01, compared to t-BHP treatment alone.
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tive stress, degenerative lesions are associated with inflam-
matory reaction [29]. Since luteolin and wedelolactone also
have anti-inflammatory potential [13,16], this may also con-
tribute to the neuroprotective potential of W. chinensis.Effect of EAW on MDA levels and neuronal cell density in
the cerebral cortex of D-galactose-treated mice
Oxidative stress is proposed to be major contributor of the
aging process and is linked to neurodegenerative disease
such as Alzheimer’s disease [30,31]. Neurodegenerative
AB
Figure 5 (See legend on next page.)
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Figure 5 Effects of EAW, luteolin and wedelolactone on t-BHP-induced cytochrome C release and changes in Bcl-2 family proteins.
PC12 cells were pretreated with EAW (25 and 50 μg/mL) or luteolin (L10, 10 μM; L20, 20 μM) or wedelolactone (W10, 10 μM; W20, 20 μM) for
24 h, then 100 μM of t-BHP was added for 3 h. (A) Cells were harvested after incubation, and the cytosolic protein extracts were prepared as
described in the text and subjected to Western immunoblotting analysis against anti- cytochrome C. The average densitometric value of
cytochrome C is shown as the mean ± SD (n = 3). # P < 0.05, compared to the solvent control (0.1% DMSO). *P < 0.05, compared to t-BHP
treatment alone. (B) After treatment, the total cell lysates were prepared and subjected to Western immunoblotting analysis against against
anti-Bcl-2, −Bcl-xL, −Bax and anti-actin. Actin was used as the loading control. The ratio of Bcl-2/Bax and Bcl-xL/Bax are shown as the mean ± SD
(n = 3). # P < 0.05, compared to the solvent control (0.1% DMSO). *P < 0.05, compared to t-BHP treatment alone.
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leads to functional declines. There has been a growing inter-
est in preventing various age-related pathologic conditions
in brain. One of strategies to slow or delay neuronal damage
is reducing brain oxidative stress. MDA is a metabolic prod-
uct of lipid peroxidation, which is generated under oxidative
stress. It has been reported that high concentration of
D-galactose may induce oxidative stress in brain [7].
Figure 7A shows that D-galactose treatment caused an in-
crease in MDA levels in the cortex compared to the control
group (P < 0.05) and that this increase was reduced by co-
administration of 10 or 25 mg/kg of EAW. Since oxidative
stress might induce cell apoptosis we investigated the effect
of D-galactose on cell apoptosis in the cortex by TUNEL
assay. This showed TUNEL-positive cells were significantly
increased in the D-galactose treated group compared to the
vehicle control group (P < 0.05), and that they were reducedFigure 6 Effects of luteolin and wedelolactone on Nrf2 nuclear translo
wedelolactone for 24 h prior, then the cells were collected for protein extract
western blotting analysis against anti-Nrf2 and anti-γ-GCS respectively. The av
compared to the solvent control (0.1% DMSO).by co-administration of EAW (P < 0.05; Figure 7B and C).
In addition, Figure 7D shows representative photomicro-
graphs of hematoxylin-eosin staining in the cortex of control
mice and mice treated with D-galactose with or without co-
administration of EAW. Neuron cells (large nucleus and
dark staining) in the sections are stained by hematoxylin-
eosin. As shown in Figure 7E, cell counts revealed that mice
treated with D-galactose for 9 weeks showed neuronal
loss in the cortex compared to the vehicle control
group (P < 0.05) and that this D-galactose-induced
neuronal cell loss was inhibited by co-administration
of EAW significantly (P < 0.05). One might be inter-
ested in knowing the dosage of EAW when applying in
the human. By using the body surface area normalization
method [32], the effective dose, 10 and 25 mg/kg, of
EAW in preventing neuronal loss in the cortex in mice
can be translated to the human equivalent dose, 0.81cation and γ-GCS expression. The cells were treated with luteolin or
ion. The nuclear protein extract and total protein extract were applied to





Figure 7 Effects of EAW on lipid peroxidation, TUNEL assay, and neuronal density in the cortext of D-galactose-treated mice. (A) MDA
levels were analyzed as described in the text. (B) Representative of TUNEL stained brain section. Arrow indicates TUNEL positive cells. (C) TUNEL
positive cells were quantified as described in the text. Data are expressed as mean ± SD (n = 6). (D) Representative hematoxylin-eosin stained
sections of the cortex in each group (200×). Scale bar: 100 μm. (E) Neuronal density calculated from the number of neurons in a 0.218 mm2
field (400x) and expressed as the mean ± SD for the number of mice indicated in the text. # P < 0.05, compared to the control group; *P < 0.05
and **P < 0.01, compared to the D-galactose-treated group.
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evaluate the effective amount of W. chinensis when used
in human for improving the health or for a therapeutic
purpose.
Conclusion
EAW suppressed t-BHP-induced cytotoxicity and apoptosis
by decreasing intracellular ROS through scavenging radicals
and activating endogenous antioxidant capacity in PC12
cells. In vivo experiment, EAW reduced D-galactose-in-
duced lipid peroxidation and neuron apoptosis in the cere-
bral cortex of mice. Further, in addition to luteolin, we
found wedelolactone, induced the nuclear translocation of
Nrf2 and the expression of γ-GCS. These results demon-
strate that W. chinensis possesses neuroprotective potential
by blocking oxidative stress-induced cell damage and that
luteolin and wedelolactone contribute to the action. Re-
search on other mechanisms by which EAW exerts its neu-
roprotective effect is currently in progress.
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